Would you consider long term avatrombopag use in patients with cirrhosis requiring higher platelet counts for medical therapy?

For example, someone needing a higher platelet count for dual antiplatelet agent use after coronary stent placement.

Answer from: at Academic Institution

In general, no, I would not use long-term avatrombopag in patients with cirrhosis requiring higher platelet counts for medical therapy due to the perceived thrombotic risk and hemostatic abnormalities of patients with liver disease.One thing to note in assessing the risk of long-term TPO mimetic the...

Comments

Medical Oncologist at MedStar Georgetown Cancer Institute
In a patient with cirrhosis and splenomegaly and a...

at University of Rochester School of Medicine and Dentistry
No, I do not routinely do that in patients with ci...

at Indiana Hemophilia and Thrombosis Center
I also don't routinely use TPO mimetics in patient...

Please select the option that best describes you:

Would you consider long term avatrombopag use in patients with cirrhosis requiring higher platelet counts for medical therapy?

Related Questions